Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Nächste SlideShare
Wird geladen in …5
×

The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges

301 Aufrufe

Veröffentlicht am

The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates ChallengesSummaryGBI Research has released its research - 'The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges'. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global pain management therapeutics market. The report analyzes the markets for pain management in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.ScopeThe scope of this report includes:- Annualized market data for the pain management market from 2001 to 2009, forecast forward to 2016.- Analysis of the leading therapeutic segments, including neuropathic pain, osteoarthritis, cancer pain, migraine and fibromyalgia.- Analysis of the pain management market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.- Market characterization of the pain management market including market size, the annual cost of therapy, sales volume and treatment usage patterns. - Key drivers and barriers that have a significant impact on the market. - Coverage of pipeline molecules in the various phases of drug development. - Competitive benchmarking of leading companies. The key companies studied in this report are Pfizer, Inc., Eli Lilly and Company, Johnson & Johnson, Novartis AG, Merck & Co Inc., and Cephalon, Inc.- Key M&A activities that have taken place in 2009 and the licensing agreements in the 2008-2009 global pain management market.Reasons to buyThe report will enhance your decision making capability. It will allow you to - Align product portfolio to the markets with high growth potential - Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth - Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety - Develop key strategic initiatives by understanding key focus areas of leading companies - Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Veröffentlicht in: Wirtschaft & Finanzen, Business
  • Hi! Get Your Professional Job-Winning Resume Here! 👉 http://bit.ly/rexumtop
       Antworten 
    Sind Sie sicher, dass Sie …  Ja  Nein
    Ihre Nachricht erscheint hier
  • Gehören Sie zu den Ersten, denen das gefällt!

The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges

  1. 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!The Future of Pain Management Therapeutics, Analysis and MarketForecasts to 2016 - Increasing Generic Competition CreatesChallengesPublished on March 2010 Report SummaryThe Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition CreatesChallengesSummaryGBI Research has released its research - The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 -Increasing Generic Competition Creates Challenges. The report provides in-depth analysis of unmet needs, drivers and barriers thatimpact the global pain management therapeutics market. The report analyzes the markets for pain management in the US, the topfive countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volumeare forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitivebenchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the globalmarkets. This report is built using data and information sourced from proprietary databases, primary and secondary research andin-house analysis by GBI Researchs team of industry experts.ScopeThe scope of this report includes:- Annualized market data for the pain management market from 2001 to 2009, forecast forward to 2016.- Analysis of the leading therapeutic segments, including neuropathic pain, osteoarthritis, cancer pain, migraine and fibromyalgia.- Analysis of the pain management market in the leading geographies of the world, which include the US, the UK, Germany, France,Italy, Spain and Japan.- Market characterization of the pain management market including market size, the annual cost of therapy, sales volume andtreatment usage patterns.- Key drivers and barriers that have a significant impact on the market.- Coverage of pipeline molecules in the various phases of drug development.- Competitive benchmarking of leading companies. The key companies studied in this report are Pfizer, Inc., Eli Lilly and Company,Johnson & Johnson, Novartis AG, Merck & Co Inc., and Cephalon, Inc.- Key M&A activities that have taken place in 2009 and the licensing agreements in the 2008-2009 global pain management market.Reasons to buyThe report will enhance your decision making capability. It will allow you to- Align product portfolio to the markets with high growth potential- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic marketspoised for strong growth- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency andbetter safetyThe Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 1/11
  2. 2. Find Industry reports, Company profilesReportLinker and Market Statistics- Develop key strategic initiatives by understanding key focus areas of leading companies- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps Table of Content1 Table of Contents1 Table of Contents 41.1 List of Tables 71.2 List of Figures 102 Global Pain Management Therapeutics Market: Introduction 132.1 GBI Research Report Guidance 133 Global Pain Management Therapeutics Market: Market Overview 143.1 Introduction 143.2 Revenue Forecast for the Global Pain Management Therapeutics Market 153.2.1 Sales Value 153.2.2 Patient Volume 163.2.3 Annual Cost of Therapy 173.2.4 Treatment Usage Patterns 183.2.5 Generics Share in the Global Pain Management Therapeutics Market 233.2.6 Sales of Leading Drugs 243.3 Pain Management Therapeutics Market Drivers 253.3.1 Increase in Diagnosed and Prescription Population 254 Global Pain Management Therapeutics Market: Therapeutic Landscape 264.1 Fibromyalgia Market 264.1.1 Introduction 264.1.2 Sales Value 264.1.3 Patient Volume 284.1.4 Annual Cost of Therapy 294.1.5 Treatment Usage Patterns 304.1.6 Drivers for Fibromyalgia Pain Market 354.1.7 Restraints for Fibromyalgia Pain Market 364.1.8 Unmet Needs 364.2 Neuropathic Pain Market 364.2.1 Introduction 364.2.2 Sales Value 374.2.3 Patient Volume 384.2.4 Annual Cost of Therapy 394.2.5 Treatment Usage Patterns 404.2.6 Drivers for Neuropathic Pain Market 454.2.7 Restraints for Neuropathic Pain Market 464.2.8 Unmet Need 464.3 Migraine Market 464.3.1 Introduction 464.3.2 Sales Value 474.3.3 Patient Volume 484.3.4 Annual Cost of Therapy 494.3.5 Treatment Usage Patterns 504.3.6 Drivers for Migraine Market 55The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 2/11
  3. 3. Find Industry reports, Company profilesReportLinker and Market Statistics4.3.7 Restraints for Migraine Market 554.3.8 Unmet Need 564.4 Cancer Pain Market 564.4.1 Introduction 564.4.2 Sales Value 564.4.3 Patient Volume 584.4.4 Annual Cost of Therapy 594.4.5 Treatment Usage Patterns 604.4.6 Drivers for Cancer Pain Market 644.4.7 Restraints for Cancer Pain Market 654.4.8 Unmet Need 654.5 Osteoarthritis Pain Market 654.5.1 Introduction 654.5.2 Sales Value 664.5.3 Patient Volume 674.5.4 Annual Cost of Therapy 684.5.5 Treatment Usage Patterns 694.5.6 Drivers for Osteoarthritis Pain Market 734.5.7 Restraints for Osteoarthritis Pain Market 744.5.8 Unmet Need 745 Global Pain Management Therapeutics Market: Geographical Landscape 755.1 Geographical Break-up 755.2 The US 775.2.1 Sales Value 775.2.2 Patient Volume 785.2.3 Annual Cost of Therapy 795.2.4 Treatment Usage Patterns 805.3 Top Five Countries in Europe 855.3.1 Sales Value 855.3.2 Patient Volume 865.3.3 Annual Cost of Therapy 875.3.4 Treatment Usage Patterns 885.4 Japan 935.4.1 Sales Value 935.4.2 Patient Volume 945.4.3 Annual Cost of Therapy 955.4.4 Treatment Usage Patterns 966 Global Pain Management Therapeutics Market: Pipeline Analysis 1026.1 Introduction 1026.1.1 Research and Development Pipeline Fibromyalgia 1036.1.2 Research and Development Pipeline Neuropathic Pain 1046.1.3 Research and Development Pipeline Migraine 1056.1.4 Research and Development Pipeline Cancer Pain 1066.1.5 Research and Development Pipeline Osteoarthritis Pain 1066.2 Profiles of Key Late-Stage Drugs in the Pain Management Market 1076.2.1 Droxopida 1076.2.2 Xyrem 1076.2.3 Vimpat (lacosamide) 1076.2.4 Qutenza (capsaicin 8%) 1086.2.5 Botox 109The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 3/11
  4. 4. Find Industry reports, Company profilesReportLinker and Market Statistics6.2.6 Tezampanel 1106.2.7 Nasalfent 1106.2.8 PF-4383119 (Tanezumab) 1117 Global Pain Management Therapeutics Market: Competitive Landscape 1127.1 Market Share Analysis 1127.2 Competitive Profiling 1127.2.1 Pfizer, Inc. 1147.2.2 Eli Lilly and Company 1157.2.3 Johnson & Johnson 1177.2.4 Endo Pharmaceuticals 1197.2.5 Novartis AG 1207.2.6 Merck & Co Inc 1227.2.7 Cephalon, Inc. 1238 Global Pain Management Therapeutics Market: Strategic Consolidations 1258.1 Overview 1258.1.1 Sanofi-Aventis Acquired 100% outstanding shares of Chattem, Inc in December 2009 1278.1.2 Dainippon Sumitomo Pharma Acquired Sepracor, Inc. in October 2009 1278.1.3 Raptor Pharmaceuticals and TorreyPines Therapeutics Merged in August 2009 1278.1.4 Alexza Pharmaceuticals Acquired Symphony Allegro in June 2009 1278.1.5 Anesiva and Arcion Therapeutics Merge in May 2009 1278.1.6 Mylan Laboratories Acquired Matrix Laboratories Limited in March 2009 1288.2 R&D Licensing Agreements 1288.2.1 Deals by Indication 1288.2.2 Deals by Phase 1298.2.3 Deals by Geography 1308.2.4 Deals by Value ($) 1318.2.5 Preclinical and Discovery 1318.2.6 Phase I 1328.2.7 Phase II 1328.2.8 Phase III 1338.2.9 Approved and Regulatory Filing 1349 Global Pain Management Therapeutics Market: Appendix 1369.1 Market Definitions 1369.2 Abbreviations 1369.3 Research Methodology 1379.3.1 Coverage 1379.3.2 Secondary Research 1389.3.3 Primary Research 1389.3.4 Forecasts 1389.3.5 Expert Panel Validation 1409.4 Contact Us 1419.5 Disclaimer 1419.6 Sources 1411.1 List of TablesTable 1: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2001-2009 16Table 2: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2009-2016 16Table 3: Pain Management Therapeutics Market, Global, Patient Volume (Millions), 2001-2009 17Table 4: Pain Management Therapeutics Market, Global, Patient Volume (Millions), 2009-2016 17Table 5: Pain Management Therapeutics Market, Global, Annual Average Cost of Therapy ($), 2001-2009 18Table 6: Pain Management Therapeutics Market, Global, Annual Average Cost of Therapy ($), 2009-2016 18The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 4/11
  5. 5. Find Industry reports, Company profilesReportLinker and Market StatisticsTable 7: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2001-2009 19Table 8: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2009-2016 20Table 9: Pain Management Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($m), 2009-2016 24Table 10: Pain Management Therapeutics Market, Global, Sales of Leading Drugs, 2009 25Table 11: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($m), 2001-2009 28Table 12: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($m), 2009-2016 28Table 13: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2001-2009 29Table 14: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2009-2016 29Table 15: Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2001-2009 30Table 16: T Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2009-2016 30Table 17: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2001-2009 32Table 18: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2009-2016 32Table 19: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Sales Value ($bn), 2001-2009 38Table 20: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Sales Value ($bn), 2009-2016 38Table 21: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Patient Volume (Millions), 2001-2009 39Table 22: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Patient Volume (Millions), 2009-2016 39Table 23: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Treatment ($), 2001-2009 40Table 24: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Treatment ($), 2009-2016 40Table 25: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Usage Patterns, 2001-2009 41Table 26: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Usage Patterns, 2009-2016 42Table 27: Pain Management Therapeutics Market, Global, Migraine Sales Value ($ bn), 2001-2009 48Table 28: Pain Management Therapeutics Market, Global, Migraine Diseases Population ($ bn), 2009-2016 48Table 29: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2001-2009 49Table 30: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2009-2016 49Table 31: Pain Management Therapeutics Market, Global, Migraine, Annual Cost of Therapy ($), 2001-2009 50Table 32: Pain Management Therapeutics Market, Global, Annual Cost of Migraine Treatment ($), 2001-2009 50Table 33: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions), 2001-2009 52Table 34: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions), 2009-2016 52Table 35: Pain Management Therapeutics Market, Global, Cancer Pain Diseases Population ($ bn), 2001-2009 58Table 36: Pain Management Therapeutics Market, Global, Cancer Pain Diseases Population ($ bn), 2009-2016 58Table 37: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2001-2009 59Table 38: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2009-2016 59Table 39: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2001-2009 60Table 40: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2009-2016 60Table 41: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns (millions), 2001-2009 61Table 42: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns (millions), 2009-2016 62Table 43: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($bn), 2001-2009 67Table 44: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($bn), 2009-2016 67Table 45: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (million), 2001-2009 68Table 46: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (million), 2009-2016 68Table 47: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2001-2009 69Table 48: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2009-2016 69Table 49: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns (million), 2001-2009 70Table 50: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns (million), 2009-2016 71Table 51: Pain Management Therapeutics Market, Global, Sales Value by Geography ($ bn), 2001-2009 77Table 52: Pain Management Therapeutics Market, Global, Sales Value by Geography ($ bn), 2009-2016 77Table 53: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2001-2009 78Table 54: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2009-2016 78Table 55: Pain Management Therapeutics Market, US, Patient Volume (million), 2001-2009 79Table 56: Pain Management Therapeutics Market, US, Patient Volume (million), 2009-2016 79The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 5/11
  6. 6. Find Industry reports, Company profilesReportLinker and Market StatisticsTable 57: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2009 80Table 58: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2009-2016 80Table 59: Pain Management Therapeutics Market, the US, Treatment Usage Patterns (million), 2001-2009 81Table 60: Pain Management Therapeutics Market, the US, Treatment Usage Patterns (million), 2009-2016 82Table 61: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2001-2009 86Table 62: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2009-2016 86Table 63: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2001-2009 87Table 64: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2009-2016 87Table 65: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2009 88Table 66: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2009-2016 88Table 67: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2001-2009 89Table 68: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2009-2016 90Table 69: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2001-2009 94Table 70: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2009-2016 94Table 71: Pain Management Therapeutics Market, Japan, Patient Volume (million), 2001-2009 95Table 72: Pain Management Therapeutics Market, Japan, Patient Volume (million), 2009-2016 95Table 73: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2001-2009 96Table 74: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2009-2016 96Table 75: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions), 2001-2009 98Table 76: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions) , 2009-2016 98Table 77: Pain Management Therapeutics Market, Global, Competitive Landscape, 2009 114Table 78: Pain Management Therapeutics Market, Merck, Pipeline Products, December 2009 116Table 79: Pain Management Therapeutics Market, Eli Lilly, Pipeline Products, 2010 117Table 80: Pain Management Therapeutics Market, J&J, Pipeline Products, 2010 120Table 81: Pain Management Therapeutics Market, Endo Pharmaceuticals, Pipeline Products, 2010 121Table 82: Pain Management Therapeutics Market, Novartis, Pipeline Products, 2010 123Table 83: Pain Management Therapeutics Market, Merck & Co, Inc., Pipeline Products, 2010 124Table 84: Cephalon Inc. Pain Pipeline Products, 2009 125Table 85: Pain Management Therapeutics Market, Global, Major M&A Deals, 2009-2010 127Table 86: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in the Preclinical Stage, 2008-2009 132Table 87: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase I, 2008-2009 133Table 88: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase II, 2008-2009 133Table 89: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase III, 2008-2009 134Table 90: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs Which are Approved or AwaitingApproval, 2008-2009 1351.2 List of FiguresFigure 1: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2000-2016 15Figure 2: Pain Management Therapeutics Market, Global, Volume (Millions), 2001-2016 16Figure 3: Pain Management Therapeutics Market, Global, Annual Cost of Therapy ($),2000-2015 17Figure 4: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2000-2015 18Figure 5: Pain Management Therapeutics Market, Global, Diseased Population (Millions),2001-2016 19Figure 6: Pain Management Therapeutics Market, Global, Treatment Seeking Population (Millions), 2001-2016 20Figure 7: Pain Management Therapeutics Market, Global, Diagnosed Population (Millions), 2001-2016 21Figure 8: Pain Management Therapeutics Market, Global, Prescription Population (Millions), 2001-2016 22Figure 9: Pain Management Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($m), 2009-2016 23Figure 10: Pain Management Therapeutics Market, Global, Growth Parameters, 2009 25Figure 11: Pain Management Therapeutics Market, Global, Sales Value by Indication (%) 2009 and 2016 26Figure 12: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($ bn), 2001-2016 27The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 6/11
  7. 7. Find Industry reports, Company profilesReportLinker and Market StatisticsFigure 13: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2001-2016 28Figure 14: Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2001-2016 29Figure 15: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2001-2009 30Figure 16: Pain Management Therapeutics Market, Global, Fibromyalgia Diseased Population (Millions), 2001-2016 32Figure 17: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Seeking Population (Millions), 2001-2016 33Figure 18: Pain Management Therapeutics Market, Global, Fibromyalgia Diagnosed Population (Millions), 2001-2016 34Figure 19: Pain Management Therapeutics Market, Global, Fibromyalgia Prescription Population (Millions), 2001-2016 35Figure 20: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2001-2016 37Figure 21: Pain Management Therapeutics Market, Global, Neuropathic Pain, Patient Volume (Millions), 2001-2016 38Figure 22: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Therapy ($), 2001-2016 39Figure 23: Pain Management Therapeutics Market, Global, Neuropathic Treatment Usage Patterns, 2001-2016 40Figure 24: Pain Management Therapeutics Market, Global, Neuropathic Pain Diseased Population (Millions), 2001-2016 42Figure 25: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Seeking Population (Millions), 2001-2016 43Figure 26: Pain Management Therapeutics Market, Global, Neuropathic Pain Diagnosed Population (Millions), 2001-2016 44Figure 27: Pain Management Therapeutics Market, Global, Neuropathic Pain Prescription Population (Millions), 2001-2016 45Figure 28: Pain Management Therapeutics Market, Global, Migraine Sales Value ($ bn),2001-2016 47Figure 29: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2001-2016 48Figure 30: Pain Management Therapeutics Market, Global, Migraine, Annual Cost of Therapy ($), 2001-2016 49Figure 31: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions) , 2001-2016 50Figure 32: Pain Management Therapeutics Market, Global, Migraine Diseased Population (Millions), 2001-2016 52Figure 33: Pain Management Therapeutics Market, Global, Migraine Treatment Seeking Population (Millions), 2001-2016 53Figure 34: Pain Management Therapeutics Market, Global, Migraine Diagnosed Population (Millions), 2001-2016 54Figure 35: Pain Management Therapeutics Market, Global, Migraine Prescription Population (Millions), 2001-2016 55Figure 36: Pain Management Therapeutics Market, Global, Cancer Pain Sales Value ($ bn),2001-2016 57Figure 37: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2001-2016 58Figure 38: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2001-2016 59Figure 39: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns, 2001-2016 60Figure 40: Pain Management Therapeutics Market, Global, Cancer Pain Diseased Population, 2001-2016 61Figure 41: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Seeking Population, 2001-2016 62Figure 42: Pain Management Therapeutics Market, Global, Cancer Pain Diagnosed Population, 2001-2016 63Figure 43: Pain Management Therapeutics Market, Global, Cancer Pain Prescription Population, 2001-2016 64Figure 44: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($ bn), 2001-2016 66Figure 45: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (Millions), 2001-2016 67Figure 46: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2001-2016 68Figure 47: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns, 2001-2016 69Figure 48: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Diseased Population, 2001-2016 70Figure 49: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Seeking Population, 2001-2016 71Figure 50: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Diagnosed Population, 2001-2016 72Figure 51: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Prescription Population, 2001-2016 73Figure 52: Pain Management Therapeutics Market, Global, Market Share by Geography, 2009 and 2016 75Figure 53: Pain Management Therapeutics Market, Global, Sales Value by Geography ($bn), 2001-2016 76Figure 54: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2001-2016 77Figure 55: Pain Management Therapeutics Market, US, Patient Volume (million), 2001-2016 78Figure 56: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2016 79Figure 57: Pain Management Therapeutics Market, US, Treatment Usage Patterns, 2001-2016 80Figure 58: Pain Management Therapeutics Market, US, Diseased Population (Millions),2001-2016 81Figure 59: Pain Management Therapeutics Market, US, Treatment Seeking Population (Millions), 2001-2016 82The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 7/11
  8. 8. Find Industry reports, Company profilesReportLinker and Market StatisticsFigure 60: Pain Management Therapeutics Market, US, Diagnosed Population (Millions),2001-2016 83Figure 61: Pain Management Therapeutics Market, US, Prescription Population (Millions),2001-2016 84Figure 62: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value($ bn), 2001-2016 85Figure 63: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2001-2016 86Figure 64: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2016 87Figure 65,: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2001-201688Figure 66: Pain Management Therapeutics Market, Top Five Countries in Europe, Diseased Population (Millions), 2001-2016 89Figure 67: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Seeking Population (Millions),2001-2016 90Figure 68: Pain Management Therapeutics Market, Top Five Countries in Europe, Diagnosed Population (Millions), 2001-2016 91Figure 69: Pain Management Therapeutics Market, Top Five Countries in Europe, Prescription Population (Millions), 2001-2016 92Figure 70: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2001-2016 93Figure 71: Pain Management Therapeutics Market, Japan, Patient Volume (million) , 2001-2016 94Figure 72: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($),2001-2016 95Figure 73: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions), 2001-2016 96Figure 74: Pain Management Therapeutics Market, Japan, Diseased Population (Millions),2001-2016 98Figure 75: Pain Management Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2001-2016 99Figure 76: Pain Management Therapeutics Market, Japan, Diagnosed Population (Millions),2001-2016 100Figure 77: Pain Management Therapeutics Market, Japan, Prescription Population (Millions), 2001-2016 101Figure 78: Pain Management Therapeutics Market, Global, R&D Pipeline by Indication, December 2009 102Figure 79: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase, December 2009 102Figure 80: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Fibromyalgia, March 2010 103Figure 81: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Neuropathic Pain, March 2010 104Figure 82: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Migraine, March 2010 105Figure 83: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Cancer Pain, March 2010 106Figure 84: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Osteoarthritis, March 2010 106Figure 85: Pain Management Therapeutics Market, Global, Market Share of Top Manufacturers, 2009 112Figure 86: Pain Management Therapeutics Market, Global, Pfizer, Share of Key Pain Drugs Revenue, 2009 114Figure 87: Pain Management Therapeutics Market, Global, Eli Lilly and Company, Share of Key Pain Drugs Revenue, 2009 116Figure 88: Pain Management Therapeutics Market, Global, Johnson & Johnson, Share of Key Pain Drugs Revenue, 2009 118Figure 89: Pain Management Therapeutics Market, Global, Endo Pharmaceuticals, Share of Key Pain Drugs Revenue, 2009 119Figure 90: Pain Management Therapeutics Market, Global, Novartis, Share of Key Pain Drugs Revenue, 2009 121Figure 91: Pain Management Therapeutics Market, Global, Merck & Co, Inc., Share of Key Pain Drugs Revenue, 2009 123Figure 92: Pain Management Therapeutics Market, Global,Cephalon, Share of Key Pain Drugs Revenue, 2009 124Figure 93: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Indication, 2008-2010 128Figure 94: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Phase, 2008-2010 129Figure 95: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Geography, 2008-2010 130Figure 96: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Value, 2008-2010, n=8 131Figure 97: GBI Research Methodology, 2010 137Figure 98: GBI Research Market Forecasting Model, 2010 140Companies mentionedPfizer, Inc.The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 8/11
  9. 9. Find Industry reports, Company profilesReportLinker and Market StatisticsEli Lilly and CompanyJohnson & JohnsonEndo PharmaceuticalsNovartis AGMerck & Co IncCephalon, Inc.The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 9/11
  10. 10. Find Industry reports, Company profilesReportLinker and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competi tion Creates Challenges Product Formats Please select the product formats and the quantity you require. 1 User License--USD 3 500.00 Quantity: _____ Site License--USD 7 000.00 Quantity: _____ Corporate License--USD 10 500.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 10/11
  11. 11. Find Industry reports, Company profilesReportLinker and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges Page 11/11

×